High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML

NCT00474006 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

398

Enrollment

NETWORK

Sponsor class

Conditions

ACUTE MYELOGENOUS LEUKEMIA

Interventions

DRUG: arm II

Sponsor

Cooperative Study Group A for Hematology